Physician profile
David M Banks
NPI 1497740906
$4,602.09
in general payments reported to CMS, 2019-2025
10 companies · $42.58 in 2025
The $42.58 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,413 · 2020: $1,286 · 2021: $554 · 2023: $66.98 · 2024: $240 · 2025: $42.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270 · Travel and Lodging: $78.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.29 |
| Travel and Lodging | $78.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,157.36 | 2019-2025 | Avenir, Persona |
| Cgg Medical INC | $2,137.30 | 2019 | |
| Pacira Therapeutics, INC. | $111.55 | 2019-2021 | |
| Depuy Synthes Sales INC. | $56.28 | 2019 | |
| Orthogrid Systems INC | $39.09 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $28.33 | 2023 | Zilretta, Exparel |
| Vertex Pharmaceuticals Incorporated | $21.11 | 2025 | |
| Medtronic, INC. | $19.77 | 2023 | V-Loc 180 |
| Sanara Medtech INC. | $18.88 | 2023 | Celleraterx |
| Smith+Nephew, INC. | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.